Newer drug on NHS for systemic anaplastic large cell lymphoma
Brentuximab vedotin recommended as treatment option for systemic anaplastic large cell lymphoma.
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Brentuximab vedotin recommended as treatment option for systemic anaplastic large cell lymphoma.
Some people with CLL now able to access venetoclax through Cancer Drugs Fund.